Study on Synergistic Anti-tumor Effect of Combination with Adriamycin and Palginhonhapwhajucwhan

팔진탕합화적환(八珍湯合化積丸)과 Adriamycin의 병용처리시 나타나는 synergistic 항종양(抗腫瘍) 효과(效果)에 관(關)한 작용기전 연구(硏究)

  • Moon, Gu (Dept. of Internal Medicine, College of Oriental Medicine Hospital, Won-kwang Univ.) ;
  • Moon, Seok-Jae (Dept. of Internal Medicine, College of Oriental Medicine Hospital, Won-kwang Univ.) ;
  • Won, Jin-Hee (Dept. of Internal Medicine, College of Oriental Medicine Hospital, Won-kwang Univ.) ;
  • Cho, Jung-Yun (Dept. of Internal Medicine, College of Oriental Medicine Hospital, Won-kwang Univ.) ;
  • Park, Sang-Gu (Dept. of Internal Medicine, College of Oriental Medicine Hospital, Won-kwang Univ.) ;
  • Song, Bong-Gil (Dept. of Internal Medicine, College of Oriental Medicine Hospital, Won-kwang Univ.) ;
  • Park, Rae-Gil (Dept. of Microbiology, College of Oriental Medicine Hospital, Won-kwang Univ.) ;
  • Lee, Byung-Gu (Dept. of Internal Medicine, College of Oriental Medicine Hospital, Won-kwang Univ.)
  • 문구 (원광대학교 한의과대학 비계내과학교실) ;
  • 문석재 (원광대학교 한의과대학 비계내과학교실) ;
  • 원진희 (원광대학교 한의과대학 비계내과학교실) ;
  • 조정연 (원광대학교 한의과대학 비계내과학교실) ;
  • 박상구 (원광대학교 한의과대학 비계내과학교실) ;
  • 송봉길 (원광대학교 한의과대학 비계내과학교실) ;
  • 박래길 (원광대학교 의과대학 미생물학교실) ;
  • 이병구 (원광대학교 한의과대학 비계내과학교실)
  • Published : 2000.11.30

Abstract

Objective : This study was designed to evaluate the synergistic effect on cytotoxicity of combination with adriamycin and Palginhonhapwhajucwhan, a traditional prescription for cancer treatment in oriental medicine, in Chang, HL-60, Hep-3B and Alexander cells. Methods : We observed cell viability in Chang, HL-60, Hep-3B, and Alexander cells by crystal violet staining. Those cells were treated with various concentrations of adriamycin alone, Palginhonhapwhajucwhan alone and combination of two medications for 10 hr. On condition of $0.5{\mu}l/ml$ adriamycin alone, $15.6{\mu}l/ml$ Paljintanghapwhajucwhan alone and combination of two medications, at first, we observed colony forming of Chang and HL-60 cells. Second, we observed DNA fragmentation by agarose electrophoresis in Chang, HL-60, Hep-38 and Alexander cells. Third, we measured the catalytic activation of caspase-1, 2, 3, 6, 8, and 9 protease in Chang cells and caspase-3 protease in Chang, HL-60, Hep-3B and Alexander cells by using fluorogenic substrate. Finally, we isolated mRNA of Fas in Chang, HL-60, Hep-38 and Alexander cells and observed that Fas gene was amplified by RT-PCR Results : 1. The combination of adriamycin and Palginhonhapwhajucwhan synergistically augmented the cytotoxicity of Chang and HL-60 cells whereas did not in Hep-38 and Alexander cells. 2. Cotreatment of two drugs also markedly inhibited the colony forming ability both in Chang and HL-60 cells. 3. The cytotoxicity of these medicatons was revealed as apoptosis characterized by high molecular wight DNA fragmentaton. 4. The apoptotic cytotoxicity was mediated by activation of caspase-3 protease in Chang cells. 5. Synergistic increase in apoptotic cytotoxicity by combination of two medications was dependent on the expression of Fas in cancer cells. Conclusions : Combination of adriamycin and Palginhonhapwhajucwhan significantly augmented apoptotic cytotoxicity of Fas-positive cells such as Chang and HL-60 cells via acticaton of apoptosis signaling pathway.

Keywords

References

  1. 腫瘤的辨證施治 錢伯文
  2. 黃帝內經 素問 王빙
  3. 黃帝內經 靈樞 王빙
  4. 諸病源候論 巢元方
  5. 病態生理學 金昌種
  6. 癌症的中藥治療 楊寶印
  7. 동양의학 v.18 no.1 癌의 中藥治療 여暢
  8. Cancer v.54 Clinical trials for the evaluation of cancer therapy Fish, B.
  9. Science v.197 no.4299 Adriamycin: the role of lipid peorxidation in cardiac toxicity and tumor response Myers, C.E.;McGuire, W.P.;Liss, R.H.;Ifrim, I.;Grotzinger, K.;Young, R.C.
  10. Am J Physiol v.261 no.4 Adriamycin-induced myocardial dysfunction in vitro is mediated by free radicals Lee, V.;Randhawa, A.K.;Singal, P.K.
  11. Immunol. Today v.14 Apoptosis Cohen, J.J.
  12. 抗癌中草藥大事典 劉春安(外)
  13. Cell v.65 Programmed cell death: apoptosis and oncogenesis Williams, G.T.
  14. 景岳全書 張介賓
  15. 東醫病理學 文濬典(외)
  16. 中醫腫瘤防治大全 李家康(外)
  17. Lakartidningen v.97 no.12 Apoptosis required for maintenance of homeostasis: familial hemophagocytic lymphohistiocytosis caused by too little cell death Fadeel, B.;Henter, J.I.;Orrenius, S.
  18. Science v.262 Programed cell death and the control of cell survival Raff, mc.;Bares, B.A.;Burne, J.F.;Coles, H.S.;Ishizaki, Y.;Jacobson, M.D.
  19. J. Patho v.173 Apoptosis in the immune system Williams, G.T.
  20. Science v.267 Apoptosis in the pathogenesis and treatment of disease Thomson, C.B.
  21. Adv. Pharmacol. v.41 Chemotherapy-induced apoptosis Mesner, P.;Budihardjo, I.;Kaufmann, S.H.
  22. Cancer Res v.40 no.11 Structural and functional effects of adriamycin on cardiac cells in vitro Lampidis, T.J.;Henderson, I.C.;Israel, M.;Canellos, G.P.
  23. J. Biol. Chem. v.273 no.12 Caspase-dependent Cleavage of signaling proteins during apoptosis Widmann, C.;Gibson, S.